Scout | Cutting-Edge Basic Research Awards (CEBRA) (R21 Clinical Trial Optional)

grant

Cutting-Edge Basic Research Awards (CEBRA) (R21 Clinical Trial Optional)

The CEBRA grant funds groundbreaking addiction research projects that are considered high-risk but have the potential for significant impact. These projects should explore new techniques or ideas not currently covered by NIDA, aiming to transform current understanding in the field.

Source

Agency: National Institutes of Health

Sub-agency: National Institute on Drug Abuse

Award

Total Funding: $150,000

Award Ceiling: $275,000

Funding Amount: $150,000

Dates

Opportunity Released: December 30, 2024

Eligibility

government

individual

industry:research

nonprofit

small_business

tribal

university

Public/State Controlled Institutions of Higher Education

Nonprofits with 501(c)(3) IRS Status (Other than Institutions of Higher Education)

For-Profit Organizations (including Small Businesses)

Local Governments

Indian/Native American Tribal Governments (Federally Recognized)

Keywords

addiction research

high-risk research

high-impact research

innovative hypotheses

revolutionary techniques

drug abuse

NIDA

cutting-edge research

transformative research methods

underrepresented research

Supporting Links

Documents

Similar Opportunities

Unlock similar opportunities

Get the full picture on this opportunity

Create a free Scout account to unlock everything you need to decide fast and win the grant.

Instant Fit Analysis

Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
Deep agency & funder detail

Program context, sub-agency structure, and a full eligibility breakdown.
Source links & full documents

Jump straight to the solicitation and download every attachment.
Similar opportunities

Discover related funding matched to your work.

Get a Demo Sign Up

Already have an account? Sign In

Trusted by 500+ Happy Customers